期刊文献+

胶原包被条件对血管性血友病因子胶原结合法测定FⅧ制品中血管性血友病因子的影响

Effect of coating condition on collagen binding assay for von Willebrand factor in FⅧ concentrate
原文传递
导出
摘要 目的通过考察不同胶原包被条件对血管性血友病因子(von willebrand factor,vWF)与胶原结合的影响,建立vWF胶原结合法(vWF collagen binding assay,vWF:CBA)检测FⅧ制品中vWF活性。方法将胶原Ⅲ分别按以下4组条件包被ELISA板:不同pH(2.8、4.0、5.2、6.4、7.4、8.8、9.8)的缓冲液,不同盐浓度(0、0.05、0.1、0.15、0.2、0.3、0.4、0.6 mol/L NaCl)的缓冲液,不同胶原Ⅲ浓度(5、2.5、1、0.5、0.25、0.125μg/ml),不同包被温度(4、25、37℃)。以5个不同稀释度的vWF标准品为样品,进行vWF:CBA法测定,每种包被条件下绘制1条标准曲线,同时检测每种包被条件下方法的重复性。将标准曲线线性和方法重复性较好的几组条件做为最佳包被条件,验证该包被条件下vWF:CBA法的特异性、重复性,获得标准曲线范围。结果当胶原Ⅲ溶解于含0.15 mol/L NaCl,pH 6.4的磷酸缓冲液中,在4℃条件下以2.5μg/ml包被时,vWF与胶原的结合效率较高。将该包被条件下的vWF:CBA法用于测定冷沉淀上清及FⅧ制品中vWF活性,具有较好的特异性和重复性。结论不同的包被条件对胶原结合法测定vWF活性具有较大的影响,因此,在采用胶原结合法测定FⅧ制品中vWF活性时,应对包被条件进行优化。 Objective To develop a von Willebrand factor(vWF)collagen binding assay(vWF:CBA)for determination of vWF activity in FⅧ concentrate by investigating the effect of various conditions for collagen coating on binding of vWF to collagen. Methods ELISA microplate was coated with collagen Ⅲ by using the buffers at various pH values(2. 8,4. 0,5. 2,6. 4,7. 4,8. 8 and 9. 8),various salt concentrations(0,0. 05,0. 1,0. 15,0. 2,0. 3,0. 4 and 0. 6 mol / L NaCl),various collagen Ⅲ concentrations(5,2. 5,1,0. 5,0. 25 and 0. 125 μg / ml)and various temperatures(4,25 and 37 ℃). The vWF standard at five dilutions were used as the samples and determined by vWF:CBA,as a result one standard curve was plotted under each coating condition. Reproducibility of the method under each coating condition was investigated. The conditions under which the linearities of standard curve and the reproducibility of method were better than the others were selected as the optimal coating condition for verification of specificity and reproducibility of VWF:CBA to obtain the range of standard curve. Results When the ELISA microplate was coated with 2. 5 μg / ml human collagen Ⅲ dissolved in the buffer containing 0. 15 mol / L NaCl at pH 6. 4 and 4 ℃,the binding capability of vWF to collagen was higher than those under other conditions. The vWF:CBA was used for determination of vWF activities in the supernatant of cryoprecipitation and in F Ⅷ concentrate under the optimized condition,and showed high specificity and reproducibility. Conclusion The coating condition showed significant effect on the determination of activity of vWF by collagen binding assay,which should be optimized before determination.
出处 《中国生物制品学杂志》 CAS CSCD 2014年第10期1333-1337,共5页 Chinese Journal of Biologicals
基金 863计划生物和医药技术领域:血浆综合利用及特免球蛋白等新产品开发(2012AA0221903)
关键词 血管性血友病因子 胶原结合法 F峪制品 包被条件 von Willebrand Factor Collagen binding assay FⅧ concentrate Coating condition
  • 相关文献

参考文献13

  • 1Starke RD, Paschalaki KE, Dyer CE, et al. Cellular and mo- lecular basis of yon Willebrand disease: studies on blood outgrowth endothelial cells [J]. Blood, 2013, 121 (14): 2773- 2784.
  • 2Samor B, Michalski C, Brandin MP, et al. A qualitative and quantitative analysis of yon Willebrand factor contained in a very high-purity plasma-derived FⅧ concentrate [J]. Vox Sang, 2012, 103 (1): 35-41.
  • 3European Pharmacopoeia Commission. European Pharmacopoeia 7.0 [S]. European Directorate for the Quality Control of Me- dicines, 2010: 2189-2190.
  • 4Flood VH, Friedman KD, Gill JC, et al. Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function [ J ]. J Thromb Haemost, 2009, 7 ( 11 ) : 1832- 1839.
  • 5Favaloro EJ. An update on the yon Willebrand factor collagen binding assay: 21 years of age beyond adolescence but not yet a mature adult [J]. Semin Thromb Hemost, 2007, 33(8): 727- 744.
  • 6Mendelboum Raviv S, Szekeres-Csiki K, Jenei A, et al. Coating conditions matter to collagen matrix formation regarding yon Willebrand factor and platelet binding [J]. Thromb Res, 2012, 129(4) : e29-e35.
  • 7Ranch A, Wohner N, Christophe OD, et ol. On the versatility of von Willebrand factor [ J ]. Mediterr J Hematol Infect Dis, 2013, 5 (1): e2013046.
  • 8Ott HW, Griesmacher A, Schnapka-Koepf M, et al. Analysis of yon Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5- labeled antibody high-sensitivity fluorescence detection [J]. Am J Clin Pathol, 2010, 133(2): 322-330.
  • 9Favaloro EJ, Bonar R, Chapman K, et al. Differential sen- sitivity of yon Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb- based assays [J]. J Thromb Haemost, 2012, 10(6): 1043-1054.
  • 10Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen [J]. Thromb Res, 1986, 43 (3): 303-311.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部